We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.92B
AUM Growth
+$154M
Cap. Flow
+$62.7M
Cap. Flow %
3.27%
Top 10 Hldgs %
26.22%
Holding
151
New
15
Increased
40
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
JELD icon
JELD-WEN Holding
JELD
+$18.8M
2
LII icon
Lennox International
LII
+$14.6M
3
AVXS
AveXis, Inc. Common Stock
AVXS
+$8.18M
4
TTD icon
Trade Desk
TTD
+$8.01M
5
VRNS icon
Varonis Systems
VRNS
+$7.91M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$21.1M
2
CYBR
CyberArk
CYBR
+$14M
3
ABBV icon
AbbVie
ABBV
+$10.1M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$9.2M
5
XPO icon
XPO
XPO
+$7.1M

Sector Composition

Rank Sector Weight
1 Healthcare 36.8%
2 Consumer Discretionary 13.92%
3 Technology 13.08%
4 Industrials 10.12%
5 Utilities 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETN icon
126
Eaton
ETN
$150B
$1M 0.05%
12,700
+2,200
+21% +$171K
CCI.PRA
127
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$852K 0.04%
755
+155
+26% +$172K
WBK
128
DELISTED
Westpac Banking Corporation
WBK
$831K 0.04%
34,100
+1,600
+5% +$39.6K
CVA
129
DELISTED
Covanta Holding Corporation
CVA
$688K 0.04%
+40,700
New +$628K
ERIC icon
130
Ericsson
ERIC
$32.1B
$635K 0.03%
95,000
-10,000
-10% -$62.3K
CIG icon
131
CEMIG Preferred Shares
CIG
$6.21B
$608K 0.03%
+578,731
New +$658K
VTR icon
132
Ventas
VTR
$44.7B
$594K 0.03%
9,900
+2,900
+41% +$183K
CWEN icon
133
Clearway Energy Class C
CWEN
$4.94B
$592K 0.03%
31,300
-39,700
-56% -$754K
AYI icon
134
Acuity Brands
AYI
$10.1B
$581K 0.03%
3,300
+1,300
+65% +$216K
EPIX
135
DELISTED
ESSA Pharma
EPIX
$576K 0.03%
135,971
– –
WELL icon
136
Welltower
WELL
$170B
$564K 0.03%
8,850
+3,350
+61% +$225K
LXP icon
137
LXP Industrial Trust
LXP
$3.52B
$531K 0.03%
11,000
– –
LPT
138
DELISTED
Liberty Property Trust
LPT
$516K 0.03%
12,000
– –
ATRC icon
139
AtriCure
ATRC
$2.04B
– –
-180,000
Closed -$4.03M
CHRS icon
140
Coherus Oncology
CHRS
$227M
– –
-145,000
Closed -$1.94M
CYBR
141
DELISTED
CyberArk
CYBR
– –
-342,000
Closed -$14M
KALA icon
142
KALA BIO
KALA
$13.6M
– –
-24
Closed -$1.37M
SNDX icon
143
Syndax Pharmaceuticals
SNDX
$1.73B
– –
-225,000
Closed -$2.63M
GBT
144
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-190,000
Closed -$5.9M
EPZM
145
DELISTED
Epizyme, Inc
EPZM
– –
-275,000
Closed -$5.24M
DRNA
146
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-377,000
Closed -$2.17M
RARX
147
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-100,000
Closed -$1.46M
RXDX
148
DELISTED
Ignyta, Inc.
RXDX
– –
-344,000
Closed -$4.25M
GLBL
149
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
– –
-160,000
Closed -$760K
2 3 4 5
6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Eventide Asset Management held 151 positions worth $1.92B, up 8.7% from $1.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $62.7M of net new capital in Q4 2017, opening 15 new positions and adding to 40 existing holdings. Its largest new stake was JELD-WEN Holding: 506,500 shares worth $19.9M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was bluebird bio, an estimated $21.1M trimmed.

  • Eventide Asset Management's largest Q4 2017 buy was JELD-WEN Holding: 506,500 shares worth $19.9M.
  • Eventide Asset Management added most to AveXis, Inc. Common Stock in Q4 2017, an estimated $8.18M increase.
  • Eventide Asset Management's biggest Q4 2017 reduction was bluebird bio, cutting an estimated $21.1M.
  • Eventide Asset Management fully exited CyberArk in Q4 2017, selling an estimated $14M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.92B portfolio in Q4 2017.
  • Eventide Asset Management opened 15 new positions and closed 11 in Q4 2017.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $1.92B.

Based on Eventide Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.